Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study
Related Experiment Videos
F Alla1, S Briançon, Y Juillière
1Department of Epidemiology and Cardiology, University Hospital, Nancy, France. f.alla@chu-nancy.fr
Insights
A new prognostic rating system for severe congestive heart failure (CHF) was developed. This tool aids physicians in patient management and clinical trial stratification by predicting 1-year survival rates.
Area of Science:
- Cardiology
- Clinical Prognostics
Background:
- Clinical management of severe congestive heart failure (CHF) requires prognosis-based grading.
- An objective was to develop a prognostic rating system for severe CHF.
Purpose of the Study:
- To elaborate a prognostic rating system for severe congestive heart failure (CHF).
Main Methods:
- The EPICAL program identified severe CHF patients (NYHA class III/IV, low ejection fraction, or high cardiothoracic index).
- Baseline variables were analyzed using Cox multivariate models.
Main Results:
- Ischemic heart disease patients had lower 1-year survival (57.6%) than dilated cardiomyopathy patients (69.1%).
- Multivariate analysis identified 5 prognostic factors for ischemic CHF and 7 for dilated cardiomyopathy CHF.
- Patients were classified into good (>75%), intermediate, or poor (=25%) 1-year survival subgroups.
Conclusions:
- A prognostic prediction score was derived from readily available data.
- This score assists physicians in decision-making and serves as a stratification tool for clinical trials.
Background:
The clinical management of severe congestive heart failure (CHF) should be graded according to the prognosis of each individual patient. Our objective was to elaborate a prognostic rating system for severe CHF.
Methods:
The EPICAL program (Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine) identified patients with severe CHF defined by hospitalization accompanied by class III/IV dyspnea, edema, or hypertension; an ejection fraction =30% or a cardiothoracic index >/=60%. Baseline variables were tested in Cox multivariate models.
Results:
Patients with ischemic heart disease (n = 219) had a lower 1-year survival rate (57.6%) than patients with dilated cardiomyopathy (n = 182) (69. 1%). Multivariate analysis identified 5 prognostic factors for ischemic CHF and 7 for CHF caused by dilated cardiomyopathy. These variables were used to classify patients within prognostic subgroups of good (>75%), intermediate, or poor (=25%) 1-year survival.
Conclusion:
A score for prognostic prediction was further derived from readily available data to help physicians improve decision making and to assist in clinical trials as a stratification tool.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies